These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 22489716)
1. Monitoring calcific aortic valve disease: the role of biomarkers. Latsios G; Tousoulis D; Androulakis E; Papageorgiou N; Synetos A; Tsioufis C; Toutouzas K; Stefanadis C Curr Med Chem; 2012; 19(16):2548-54. PubMed ID: 22489716 [TBL] [Abstract][Full Text] [Related]
2. Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks. Pasipoularides A J Cardiovasc Transl Res; 2016 Apr; 9(2):102-18. PubMed ID: 26891845 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease. Cho KI; Sakuma I; Sohn IS; Jo SH; Koh KK Atherosclerosis; 2018 Oct; 277():60-65. PubMed ID: 30173080 [TBL] [Abstract][Full Text] [Related]
4. The lipid theory in the pathogenesis of calcific aortic stenosis. Parisi V; Leosco D; Ferro G; Bevilacqua A; Pagano G; de Lucia C; Perrone Filardi P; Caruso A; Rengo G; Ferrara N Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):519-25. PubMed ID: 25816732 [TBL] [Abstract][Full Text] [Related]
5. Histopathology of calcific aortic valve stenosis. Somers P; Knaapen M; Mistiaen W Acta Cardiol; 2006 Oct; 61(5):557-62. PubMed ID: 17117757 [TBL] [Abstract][Full Text] [Related]
6. Systemic and local levels of fetuin-A in calcific aortic valve stenosis. Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637 [TBL] [Abstract][Full Text] [Related]
7. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops. Li C; Xu S; Gotlieb AI Cardiovasc Pathol; 2013; 22(1):1-8. PubMed ID: 22795219 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Utility of Neutrophil-to-Lymphocyte Ratio on Adverse Clinical Outcomes in Patients with Severe Calcific Aortic Stenosis. Cho KI; Cho SH; Her AY; Singh GB; Shin ES PLoS One; 2016; 11(8):e0161530. PubMed ID: 27548384 [TBL] [Abstract][Full Text] [Related]
12. The global burden of aortic stenosis. Thaden JJ; Nkomo VT; Enriquez-Sarano M Prog Cardiovasc Dis; 2014; 56(6):565-71. PubMed ID: 24838132 [TBL] [Abstract][Full Text] [Related]
13. Blood, tissue and imaging biomarkers in calcific aortic valve stenosis: past, present and future. Shen M; Tastet L; Bergler-Klein J; Pibarot P; Clavel MA Curr Opin Cardiol; 2018 Mar; 33(2):125-133. PubMed ID: 29194051 [TBL] [Abstract][Full Text] [Related]
14. Patients with calcific aortic stenosis exhibit systemic molecular evidence of ischemia, enhanced coagulation, oxidative stress and impaired cholesterol transport. Mourino-Alvarez L; Baldan-Martin M; Gonzalez-Calero L; Martinez-Laborde C; Sastre-Oliva T; Moreno-Luna R; Lopez-Almodovar LF; Sanchez PL; Fernandez-Aviles F; Vivanco F; Padial LR; Akerstrom F; Alvarez-Llamas G; de la Cuesta F; Barderas MG Int J Cardiol; 2016 Dec; 225():99-106. PubMed ID: 27716559 [TBL] [Abstract][Full Text] [Related]
18. The mechanism of the obstruction in calcific aortic stenosis with bicuspid valve: a reason for failure of balloon aortic valvuloplasty in the elderly. Di Segni E; Bakst A; Levi A; Rosenschein U; Klein HO Cardiology; 1989; 76(6):450-4. PubMed ID: 2611797 [TBL] [Abstract][Full Text] [Related]
19. Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis. Patel N; Kumbhani DJ Curr Heart Fail Rep; 2018 Oct; 15(5):281-286. PubMed ID: 30062624 [TBL] [Abstract][Full Text] [Related]
20. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation. Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]